The data reported here are a comparison among four different methods for the detection of carbonylated proteins, a validated biomarker of oxidative stress. The reference samples were heart and kidney extracts of Guinea pigs transfused with hemoglobinbased oxygen carriers (Alomari et al. FRBM, [11] ). We measured the carbonyl content of organ extracts by using i) the Levine spectrophotometric method, which takes advantage of the chromogenic reaction of carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH), ii) a commercially available ELISA assay based on an anti-DNPH antibodies, iii) a commercially available Western blot method based on anti-DNPH antibodies and iv) an in-gel detection approach with the fluorophoric reagent fluorescein-5-thiosemicarbazide. The former two methods measure total protein carbonylation of a sample, whereas the latter two require an electrophoretic separation and therefore potentially allow for the identification of specific carbonylated proteins.
Specifications
Hemoglobin-and myoglobin-containing samples can also be analyzed with spectrophotometric methods upon removal of the heme.
Detection of carbonylated proteins upon electrophoretic separation can be carried out both by
Western blot and by in-gel fluorophoric tagging -a significantly less expensive approach -with similar results.
Data
The total carbonyl content as detected in heart tissue with the Levine method and the ELISA method (OxiSelect™ Protein Carbonyl ELISA Kit, Cell Biolabs, San Diego, CA, USA) is reported in Fig. 1 for the three animal groups described in FRBM [11] . No significant difference was observed between the two methods, with the ELISA method being more expensive.
Values measured with two methods on each sample are correlated (Pearson correlation coefficient ¼ 0.588, p ¼ 0.0442) (Fig. 2) .
Since the ELISA assay is particularly advised for heme-containing samples -as heme interferes with DNPH spectroscopic measurement -we introduced an additional step to allow measuring the carbonyl content on hemoglobin/myoglobin-rich kidney extracts by the Levine method (see Section 2) . Without the heme removal step, the absorption contribution of heme groups in a non DNPH-treated sample dominates the 340-400 nm absorption range (Fig. 3, red line) . The additional step for heme removal (see Section 2) fully eliminates the absorption contribution of the heme (Fig. 3 , blue line), allowing for carbonylation to be easily detected when DNPH labelling is performed (Fig. 3, black line) .
The results on the evaluation of carbonyl content with the two methods applicable after electrophoretic separation are shown in Fig. 4 . Fig. 4a shows a Western blot developed with the Oxyblot assay and the corresponding SDS-PAGE used for data normalization (Fig. 4b) . The total carbonyl contents estimated from the Western blot are reported in Fig. 4c . Fig. 4d -f represents the corresponding results with the fluorescein-5-thiosemicarbazide (FTC)-derivation method.
Experimental design, materials and methods

Sample preparation
Heart and kidney tissue samples were obtained from 14 Hartley Guinea pigs that underwent either autotransfusion or transfusion with PEG-Hb oxy or PEG-Hb deoxy , two PEGylated hemoglobin-based oxygen carriers [1] [2] [3] [4] [5] [6] endowed with different oxygen affinity [2] , as described in FRBM [11] . The aim of the work was to assess the degree of oxidative stress in the treatment groups in comparison with the control (autotransfused) group by determining the level of carbonylated proteins. No significant differences among groups were observed.
Detection of protein carbonylation
Samples for carbonyl detection were obtained from individual hearts and kidneys that were cryogenically ground with mortar and pestle and resuspended in a solution containing 50 mM phosphate buffer, pH 7.4, 1% DTT, in the presence of a protease inhibitor cocktail mixture (SigmaAldrich, St. Louis, MO, USA). The total protein content of the extracts, assessed using the Bradford assay (Bio-Rad Laboratories, Inc., Hercules, California, USA), was 1.2 7 0.3 mg/mL.
Levine spectrophotometric method
The carbonyl content of whole protein extracts was measured using the Levine method [7, 8] , in which carbonylated proteins are derivatized with 2,4-dinitrophenylhydrazine (DNPH) to produce a chromophoric adduct exhibiting an extinction coefficient of 22,000 M À 1 cm À 1 at 366 nm. DNPH at 5 mM concentration was added to 500 μL aliquots of 1.2 mg/mL protein solutions and left to react for 1 h in the dark. Proteins were then precipitated with 10% trichloroacetic acid (TCA) and extensively washed with 10% TCA, followed by two washing steps with ethanol/ethyl acetate (1:1 v/v). The resulting pellet was solubilized in 6 M guanidinium hydrochloride. Spectra were collected in the 250-600 nm range, which allowed assessing both the protein concentration, from absorbance at 280 nm, and that of the DNPH derivatives, from absorbance at 366 nm. To take into account the contribution of heme proteins to the same absorption range as DNPH, the spectra of control protein samples that underwent all steps with the exception of DNPH derivatization were used as a reference. All spectra were normalized to the total protein content of each sample, as assessed by absorbance at 280 nm, assuming that one unit of absorbance corresponds to a protein concentration of 1 mg/mL. For kidney extracts, that exhibited a high heme content, a modified protocol was applied, which included an additional protein precipitation step with HCl-acetone (3:100 v/v) before addition of DNPH to remove the heme moiety [9] .
ELISA detection of carbonylated proteins
The OxiSelect™ Protein Carbonyl ELISA Kit (Cell Biolabs, San Diego, CA, USA) was applied to the same protein samples used for the Levine method in a 96-wells plate, according to the manufacturer's instructions. The chromogenic reaction catalyzed by horseradish peroxidase (HRP) was detected using a plate reader (Halo LED 96 -Dynamica Scientific Ltd., Newton Pagnell, UK). Calibration was performed using the calibrants provided by the manufacturer.
Detection of protein carbonylation by western blot
For immunoblotting, samples containing 2 μg of protein were loaded onto two 12% SDS-PAGE gels.
One gel was developed with Coomassie blue and the other was electroblotted to a nitrocellulose membrane with a Trans-Blot Turbo Blotting System (Bio-Rad Laboratories, Inc., Hercules, California, USA). The membranes were then incubated overnight at 4°C in 2% BSA blocking solution and probed with a rabbit anti-DNPH antibody in a 1/150 dilution (OxyBlot™ Protein Oxidation Detection Kit, Merk Millipore, Darmstadt, Germany). The membrane was then probed with a goat anti-rabbit secondary antibody conjugated to HRP according to the manufacturer's instructions. Upon addition of the substrate CheLuminate-HRP PicoDetect (PanReac AppliChem, Darmstadt, Germany), the chemiluminescence signals were captured with a ChemiDoc ™ system (Bio-Rad Laboratories, Inc., Hercules, California, USA). Western blot signals were normalized to Coomassie blue signals measured on the partner SDS-PAGE gel and expressed as arbitrary units.
In-gel detection with fluorescein-5-thiosemicarbazide
In-gel detection upon derivatization with FTC was carried out using the protocol reported in [10] . Briefly, FTC was added in a ratio 1:4 v/v to protein solutions to give a 1 mM final concentration and incubated in the dark for 150 min at room temperature with gentle mixing every 30 min. Proteins were then precipitated with an equal volume of ice-cold 20% TCA (v/v). Mixtures were incubated at 4 
Statistical analysis
Statistically significant changes were assessed by one-way analysis of variance (ANOVA) follow by Tukey's Test. In all analyses, a value p o 0.05 was taken as the level of statistical significance. In all plots, values are represented as mean 7 standard error (SE). Graphs and statistical analyses were performed using the software SigmaPlot (Systat Software, San Jose, CA, USA).
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